BTG plc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 11-Jun-08

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

BTG was initially formed as a group focused on technology commercialization in two operating areas: life sciences and physical sciences. Later in 2006, the company changed its focus to become a purely life sciences company and began divestment of its physical sciences business.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    BTG is a life sciences company focused on the development and commercialization of pharmaceuticals principally targeting neuroscience and oncology. The company's proprietary product candidates in clinical development include: Varisolve for Varicose veins (Phase II);

    The company's total revenues increased at a CAGR of 14% during 2002-2006, from $33 million to $56 million, representing an absolute growth of +$23 million. The company derives all of its revenues from royalties on products marketed by its licensees and the proceeds of one-off deals, settlements or milestone payments.

    The key elements of the company's business strategy is to build a balanced pipeline of preclinical and clinical programs, emerge as pure life sciences company, and enter into licensing and collaboration with other pharmaceutical/biotechnology companies.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: BTG btg swot analysis plc company strategy mccubbin steven myint paul

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.